Lundbeck Center for Translational Science in Clinical Research
The Lundbeck Foundation has donated 3 million EUR to the funding of a COPSAC Center for Translational Science in Clinical Research. The vision is to develop new knowledge on the origins of asthma, allergy and atopic dermatitis in order to provide a basis for the development of preventive measures, novel diagnostic tests and therapeutics for these chronic diseases.
Relating findings at the molecular level to clinical phenotypes is a central problem for medical science. This research program springs from clinical research designed as prospective, longitudinal birth cohort studies on asthma, allergy and atopic dermatitis and transgresses this clinical research program by close collaboration with basic researchers in genetics, microbiology and statistics.
The structure of the program is a consortium of the 3 academic centres of COPSAC, Centre for Applied Genomics at Children Hospital of Philadelphia and Department of Bacteriology at Statens Serum Institut in Denmark.
This novel human-based research with its ambitious and well defined scientific and technological objectives will bring Danish medical research to the international forefront of research into the origins of asthma by bridging comprehensive objective longitudinal clinical phenotyping with cutting-edge DNA technologies.
